Literature DB >> 21393460

New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia.

Briony Elliott1, Michelle M Squire1, Sara Thean2, Barbara J Chang1, Jon S Brazier3, Maja Rupnik4, Thomas V Riley2,1.   

Abstract

A total of 817 human clinical isolates of Clostridium difficile from all Australian states were screened for A(-)B(+) strains by toxin gene PCR assays. Nine (1.1 %) strains were confirmed to be A(-)B(+) by enzyme immunoassay for toxin production. Of these, six (66.7 %) were binary toxin-positive by PCR. Using PCR ribotyping and toxinotyping, the A(-)B(+) strains could be grouped into seven ribotypes and three toxinotypes. Only one of the ribotypes had been reported previously (017). The prevalence of ribotype 017 was low in this study with only two strains detected. Two new A(-)B(+) toxinotypes were also defined (XXX, XXXI). Toxinotype XXX had a toxin B gene similar to that of toxinotype IV (A(+)B(+)) but with a novel cytopathic region. Toxinotype XXXI was similar to other A(-)B(+) types (X, XVII), but had a larger deletion to the toxin A gene than in either of those types. The types of A(-)B(+) strains identified in this study differed markedly from those described in other regions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393460     DOI: 10.1099/jmm.0.031062-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  33 in total

1.  A small-molecule antivirulence agent for treating Clostridium difficile infection.

Authors:  Kristina Oresic Bender; Megan Garland; Jessica A Ferreyra; Andrew J Hryckowian; Matthew A Child; Aaron W Puri; David E Solow-Cordero; Steven K Higginbottom; Ehud Segal; Niaz Banaei; Aimee Shen; Justin L Sonnenburg; Matthew Bogyo
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

Review 2.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.

Authors:  Jari J Hirvonen; Silja Mentula; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 4.  An Update on Clostridium difficile Toxinotyping.

Authors:  Maja Rupnik; Sandra Janezic
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

Review 5.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

6.  Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Authors:  Elisabeth M Terveer; Monique J T Crobach; Ingrid M J G Sanders; Margreet C Vos; Cees M Verduin; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

7.  Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.

Authors:  Grace O Androga; Alan M McGovern; Briony Elliott; Barbara J Chang; Timothy T Perkins; Niki F Foster; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 9.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

10.  tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile.

Authors:  Brianne Couturier; Robert Schlaberg; Chris Konzak; Jeff Nicholes; Christian Law; Rosemary C She
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.